1369967-05-4

Basic information

• Product Name: N-(3-phenyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)acetamide
• CAS NO: 1369967-05-4
• Molecular Weight: 272.371
• Mol File: 1369967-05-4.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-(3-phenyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(3-phenyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)acetamide(1369967-05-4)
• EPA Substance Registry System: N-(3-phenyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)acetamide(1369967-05-4)

Safety Data

• Hazardous Substances Data: 1369967-05-4(Hazardous Substances Data)

Upstream product

• 193537-14-3 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3,6-dicarboxylic acid 6-tert-butyl ester 3-ethyl ester 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 1369967-31-6 2-acetamido-6-(tert-butoxycarbonyl)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxylic acid 
• 1369966-95-9 N-(3-bromo-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)acetamide 
• 98-80-6 phenylboronic acid 

Relevant articles and documents

INHIBITORS OF HUMAN APURINIC/APYRIMIDINIC ENDONUCLEASE 1

Disclosed are inhibitors of human APE1, for example, of formula (I), wherein A, B, X, R2, and R3 are as defined herein, that are useful in treating an APE1 mediated disease or disorder, e.g., cancer. Also disclosed is a composition comprising a pharmaceutically suitable carrier and at least one compound of the invention, a method of treating cancer in a mammal and a method of potentiating treatment of cancer.